Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial inTelligence as Tool for Early Diagnosis and Precision Surgery in eNdometriosis-related ovArian Cancer

NCT05161949 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT05161949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial inTelligence as Tool for Early Diagnosis and Precision Surgery in eNdometriosis-related ovArian Cancer
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Unknown status
Start date
November 29, 2021
Completion date
November 28, 2023
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non oncological patients or with endometriosis, patients with suspected ovarian carcinoma